References
- Badiee P, Alborzi A, Shakiba E, et al (2011). Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents. EMHJ, 17, 425-30.
- Badiee P, Alborzi A (2011). Susceptibility of clinical Candida species isolates to antifungal agents by E-test, Southern Iran: A five year study. Iran J Microbiol, 3, 183-8.
- Badiee P, Alborzi A, Shakiba E, et al (2009). Molecular identification and in-vitro susceptibility of Candida albicans and Candida dubliniensis isolated from Immunocompromised patients. Iranian Red Cres Med J, 11, 391-7.
- Blumberg HM, Jarvis WR, Soucie JM (2001). Risk factors for Candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis, 33, 177-86. https://doi.org/10.1086/321811
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial. Susceptibility testing, 16thinformational supplement (2010). M100-S16. Clinical and Laboratory Standards. Institute Wayne, USA.
- Colomboa AL, Guimaresb T, Camargoa LFA, et al (2013). Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies. Braz J Infect Dis, 17, 283-312. https://doi.org/10.1016/j.bjid.2013.02.001
- Edmond MB, Wallace SE, McClish DK, et al (1999). Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis, 29, 239-44. https://doi.org/10.1086/520192
- Fridkin SK (2005). Candidemia is costly - plain and simple. Clin Infect Dis, 41, 1240-1. https://doi.org/10.1086/496935
- Hadley S, Lee WW, Ruthazer R, et al (2002). Candidemia as a cause of septic shock and multiple organ failure in non-immunocompromised patients. Crit Care Med, 30, 1808-14. https://doi.org/10.1097/00003246-200208000-00023
- Hajjeh RA, Sofair AN, Harrison LH (2004). Incidence of bloodstream infections due to Candida species and susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol, 42, 1519-27. https://doi.org/10.1128/JCM.42.4.1519-1527.2004
- Iranparast S, Assarehzadegan MA, Heike Y, et al (2014). Wilms' tumor gene (WT1) expression correlates with vascular epithelial growth factor (VEGF) in Newly Acute Leukemia Patients Undergoing Chemotherapy. Asian Pac J Cancer Prev, 15, 9217-23 https://doi.org/10.7314/APJCP.2014.15.21.9217
- Ligozzi M and Fontana R (2003). Isolation of total DNA from bacteria and yeast. African J Biotechnol, 2, 251-3. https://doi.org/10.5897/AJB2003.000-1052
- Mousavi S, Gouya M, Ramazani M, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-3.
- Naghavi M (2003). Mortality views in 23 provinces of Iran 2003. Tehran, Iran: ministry of health, deputy to health directory. Res Development Office, 7, 75-6.
- Nolte FS, Parkinson T, Falconer DJ, et al (1997). Isolation and characterization of fluconazole- and amphotericin B-Resistant Candida albicans from Blood of Two Patients with Leukemia. Antimicrob Agents Chemother, 14, 196-9.
- Theoklis E. Argon J, Chu J, et al (2005). The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis, 41, 1232-9. https://doi.org/10.1086/496922
Cited by
- biofilms: state of knowledge and new options for prevention and eradication vol.11, pp.2, 2016, https://doi.org/10.2217/fmb.15.139